Filing Flows

Filing Flows › Prokidney (PROK) › Next earnings date

Prokidney (PROK) earnings on Nov 9, 2026: what to expect

Prokidney (PROK) is expected to report earnings on Nov 9, 2026 (estimated), tomorrow, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.14 (−$0.17 to −$0.12, 4 estimates) on revenue of $125K, against −$0.12 and $217K a year ago. It beat the EPS estimate in 50% of the quarters on record; Filing Flows' model gives it a 64% chance of beating next time.

Report dateNov 9, 2026 (estimated)
Days to go1
EPS estimate−$0.14
Revenue estimate$125K
Beat rate50%

What to watch

Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:

Prokidney: revenue lines, growth year over year, Q2 2026Prokidney: revenue lines, growth year over year, Q2 2026Revenue-32%

Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS −$0.12 on revenue of $185K, against the analysts' −$0.14.

The last report

Prokidney reported revenue of $150K for the second quarter 2026 (-32% Y/Y), net loss $46.4M. How it makes money → · Every quarter →

Prokidney: EPS against the estimate, last 4 reportsProkidney: EPS against the estimate, last 4 reportsEstimateReported−$0.14−$0.12Nov 25−$0.15−$0.14Mar 26−$0.14−$0.14May 26−$0.14−$0.15Aug 26
Latest (Aug 26): Estimate −$0.14, Reported −$0.15.

Prokidney's latest quarter

Prokidney, Q2 2026: revenue $150K (-32% year over year), net loss $46.4M, operating cash flow −$40.4M. The chart follows the revenue to costs, profit and cash.

Questions

When does PROK report earnings?

Prokidney is expected to report on Nov 9, 2026 (estimated).

What are analysts expecting from Prokidney?

EPS of −$0.14 and revenue of $125K for the quarter.

Does Prokidney usually beat earnings?

It beat the consensus EPS estimate in 50% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.